Home

Nation

States

International

Politics

Opinion

Economy

Sports

Entertainment

Trending:

Searched Tag: indian pharma

The scheme has a total outlay of ₹5,000 crore and was notified on August 17, 2023

R&D scheme for pharma soon

September 16, 2025, 04:06 PM - 3 min read

The Promotion of Research and Innovation in Pharma MedTech sector (PRIP) scheme was notified on August 17, 2023, with a total financial outlay of ₹5,000 crore, of which ₹4,250 crore is slated to accelerate investments in the R&D ecosystem

Swiss multinational healthcare company, Roche Pharma, said on Saturday it has partnered with ten government hospitals in India to strengthen clinical trial capabilities and help bring in innovations

Roche to partner with Indian govt hospitals for clinical trials

September 13, 2025, 08:23 PM - 2 min read

Swiss multinational healthcare company, Roche Pharma, said on Saturday it has partnered with 10 Indian government hospitals to equip them with world-class clinical trial capabilities

The manufacturer and marketing companies shall issue a revised price list or supplementary price list to the dealers, retailers, state drug controllers and the government, reflecting the revised GST rates and revised MRP, the National Pharmaceutical Pricing Authority (NPPA) stated

NPPA asks pharma units to pass on GST rate cuts

September 13, 2025, 02:53 PM - 2 min read

The National Pharmaceutical Pricing Authority has asked pharmaceutical companies and medical device makers to pass on the benefit of reduced GST rates to consumers with effect from September 22

Not only will this step bring relief to patients and their families, improve accessibility of medicines and quality healthcare, it will also reduce the financial strain on healthcare providers, opined pharmaceuticals and healthcare industry players on Thursday

Pharma ind terms GST cut on drugs, medical supplies 'historical'

September 4, 2025, 03:47 PM - 3 min read

The GST Council has made a bold move to remove GST on 33 life-saving drugs and three critical drugs, placing healthcare above profit, said representatives from top pharmaceutical companies in India

The company’s CFO, Santhanam Subramanian, said in an analyst call that they expect the facility to break even at the EBITDA (earnings before interest, taxes, depreciation, and amortisation) level by Q3 FY26

Indian pharma facility in China may break even at EBITDA level

August 17, 2025, 03:26 PM - 2 min read

The Hyderabad-based Aurobindo Pharma expects its China facility, where operations commenced November, 2024, to break even in the third quarter of the current financial year

India supplies over 40 per cent of generic drugs used in the US, including treatments for chronic diseases, cancer, and infectious conditions

‘Tariffs on Indian pharma would burden American consumers’

August 7, 2025, 06:51 PM - 4 min read

India’s Pharmaceutical Export Promotion Council (Pharmexcil) said on Thursday that exempting drug formulations and active pharmaceutical ingredients (API) from tariffs reiterates that India manufactures low-cost essential generic drugs and any rise in their costs will ultimately burden the American consumers.

US tariffs to hit India’s pharma; auto sector not so much

March 9, 2025, 02:55 PM - 4 min read

Smaller drug firms operating on thin margins can face severe pressure potentially forcing consolidation or closure.